Clinical and histopathological tumour progression in ECL cell carcinoids (“ECLomas”)

199978 citationsJournal Article

Authors

Gunnar Qvigstad · Norwegian University of Science and Technology

Sture Falkmer · Norwegian University of Science and Technology

Helge L. Waldum · Norwegian University of Science and Technology

Abstract

ECLomas secondary to hypergastrinemia should be closely followed for signs of clinical and histopathological tumour progression. Such ECLomas deserve early, active, radical surgical treatment. The TSA technique is a valuable tool for visualizing the characteristic IHC features in dedifferentiated NE cells.

Topics & Keywords

Neuroendocrine Tumor Research Advances Neuroblastoma Research and Treatments Lung Cancer Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Apmis

Volume 107, Issue 7-12, pp. 1085-1092

DOI: 10.1111/j.1699-0463.1999.tb01513.x

Field-Weighted Citation Impact: 2.74